Absorbable Nasal Implant Devices Market by Product Type (Drug Eluting Absorbable Nasal Implant Devices, Non-Drug Eluting Nasal Implants Devices), By Material Type (Polymer, Carboxy Methyl Cellulose (CMC), Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography.  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Absorbable nasal implant devices market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, material type, end-user and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Absorbable nasal implant devices are used in the treatment of nasal obstructions and blockage to allow better breathing. Nasal airway obstruction is caused due to enlarged turbinate, septal deviation, and vestibular stenosis among others. The most common symptoms associated with nasal airway obstruction include congestion, stuffiness, or abnormality in breathing through nostrils. Absorbable nasal implants available as spacer, springs, sponges, and gels. Absorbable implants are commonly preferred over non-absorbable implants to avoid the secondary surgery which is required to remove the non-absorbable implants. Absorbable nasal implant devices preferred over non-absorbable nasal implant devices owing to reduced adverse reactions and no delayed post-operative cosmetic changes. These devices are operated with minimally invasive techniques and have reasonable efficiency of drug-eluting implants with decrease in physiological tissue damage. Moreover, acquisitions and mergers, product approvals, and patent grants are the strategies adopted by the market players for dominating the absorbable nasal implant devices market. For instance, in July 2016, Spirox received FDA Clarence for Latera, an absorbable nasal implant to support the lower and upper lateral nasal cartilages to prevent nasal valve collapse.

Absorbable Nasal Implant Devices Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Absorbable Nasal Implant Devices Market Dynamics

Increase in the R&D for the innovation of novel absorbable nasal implants with advanced technologies such as decreased irritation & side effects spurs the absorbable nasal implant devices market over the forecast period. Moreover, rise in demand for absorbable nasal implants to avoid secondary surgery, adoption of advanced implants by physicians, relief from nasal congestion, and enhanced respiration ability are bolster the absorbable nasal implant devices market. However, stringent regulatory policies for product approval, product recall, mild pain and irritation with devices, and lack of awareness about absorbable implants among key stakeholders are expectd to restrain the growth of the market over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Absorbable Nasal Implant Devices Market Segmentation

Product Type
  • Drug Eluting Absorbable Nasal Implant Devices
  • Non-Drug Eluting Nasal Implants Devices
Material Type
  • Polymer
  • Carboxy Methyl Cellulose (CMC)
  • Others
End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Smith & Nephew plc (U.K.)
  • Pfizer, Inc. (U.S.)
  • Intersect ENT, Inc. (U.S.)
  • ArthroCare Corporation (Smith & Nephew, Inc.) (U.S.)
  • Spirox, Inc. (Entellus Medical) (U.S.)
  • Stryker Corporation (U.S.)
  • Mentor Worldwide LLC (U.S.)
  • Acclarent, Inc. (Ethicon Inc.) (U.S.)